REQUEST A DEMO
Total
USD $0.00
Search more companies

Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Hiper Farma Ilac Ticaret Ve Pazarlama Limited Sirketi Profile Updated: May 30, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti. is an enterprise in Turkiye, with the main office in Istanbul. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on March 29, 2011. 23 (2024) employees currently work for Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti.. There was a net sales revenue increase of 66.89% reported in Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti.’s latest financial highlights for 2020. Its total assets grew by 103.1% over the same period.

Headquarters
No:102 Orhantepe Mahallesi Orhangazi Caddesi Kartal
Istanbul; Marmara; Postal Code: 34865

Contact Details: Purchase the Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti. report to view the information.

Website: http://www.hiperfarma.com.tr

Basic Information
Total Employees:
Purchase the Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti. report to view the information.
Incorporation Date:
March 29, 2011
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Hiper Farma Ilac Ticaret Ve Pazarlama Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
66.89%
Total operating revenue
66.89%
Operating profit (EBIT)
37.93%
Net Profit (Loss) for the Period
N/A
Total assets
103.1%
Total equity
12.61%
Operating Profit Margin (ROS)
-1.33%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
257.71%
Quick Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?